Product
YK0901
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
Phase I Clinical Study of YK0901 Injection for the Treatment of Advanced Solid Tumors With HLA-A * 11:01 Positive and KRAS G12V MutationStatus: Not yet recruiting, Estimated PCD: 2024-07-01